Glycoprotein alpha



Glycoprotein alpha

Q1QQ1D2DD2C3CC3P4PP4E5EE5C6CC6T7TT7L8LL8Q9QQ9E10EE10N11NN11P12PP12L13LL13F14FF14S15SS15Q16QQ16P17PP17G18GG18A19AA19P20PP20I21II21L22LL22Q23QQ23C24CC24M25MM25G26GG26C27CC27C28CC28F29FF29S30SS30R31RR31A32AA32Y33YY33P34PP34T35TT35P36PP36L37LL37R38RR38S39SS39K40KK40K41KK41T42TT42M43MM43L44LL44V45VV45Q46QQ46K47KK47... and 42 more residue(s)...... and 42 more residue(s)

SMILES None
InChIKey None
Sequence QDCPECTLQENPLFSQPGAPILQCMGCCFSRAYPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKSX

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections

Structure pdb 8I2G

No bioactivity data available.

Glycoprotein alpha

Q1QQ1D2DD2C3CC3P4PP4E5EE5C6CC6T7TT7L8LL8Q9QQ9E10EE10N11NN11P12PP12L13LL13F14FF14S15SS15Q16QQ16P17PP17G18GG18A19AA19P20PP20I21II21L22LL22Q23QQ23C24CC24M25MM25G26GG26C27CC27C28CC28F29FF29S30SS30R31RR31A32AA32Y33YY33P34PP34T35TT35P36PP36L37LL37R38RR38S39SS39K40KK40K41KK41T42TT42M43MM43L44LL44V45VV45Q46QQ46K47KK47... and 42 more residue(s)...... and 42 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Structure pdb 8I2G

Compound is not listed as a drug.